Abiopharma

EMMAUS LIFE SCIENCES, INC. (EMMA)

Symbol	EMMA
Name	EMMAUS LIFE SCIENCES, INC.
Sector	UNDEFINED
Region	North America
Industry	-
Address	90503 United States CA 21250 Hawthorne Boulevard Suite 800
Telephone	(310) 214-0065
Fax	—
Email	—
Website	http://www.emmauslifesciences.com
Incorporation	US
Incorporated On	1987
Employees	—
Fiscal Year	12/31
Public Since	—
Exchanges	OTC;NASDAQ
Auditor	CBIZ CPAs P.C.;
Audit Status	AUDITED
Reporting Status	U.S. Reporting: SEC Reporting
CIK	0000822370
Description	Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease. Additional info from OTC: Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease.

2026-03-31 02:00

Emmaus Life Sciences Reports Annual Financial Results

2026-03-04 21:05

(99% Neutral) EMMAUS LIFE SCIENCES, INC. (EMMA) Announces Business Combination

2025-12-22 21:01

(99% Neutral) Emmaus Life Sciences, Inc. (EMMA) Announces Business Combination

2025-12-19 21:05

(99% Neutral) Emmaus Life Sciences, Inc. (EMMA) Announces Executive Changes

2025-11-14 20:10

Emmaus Life Sciences, Inc. (EMMA) Files Form 10-Q

2025-08-14 00:00

(42% Neutral) EMMAUS LIFE SCIENCES, INC. (EMMA) Reports 60% Loss Increase for 2025-06-30

2025-07-01 20:01

(99% Neutral) Emmaus Life Sciences, Inc. (EMMA) Announces Executive Changes

2025-05-15 20:32

(30% Negative) Emmaus Life Sciences, Inc. (EMMA) Reports Q2 2025 Financial Results

2025-05-15 00:00

(56% Neutral) EMMAUS LIFE SCIENCES, INC. (EMMA) Reports 47% Loss Reduction for 2025-03-31

2025-04-14 21:11

(82% Negative) Emmaus Life Sciences, Inc. (EMMA) Reports Q2 2025 Financial Results